Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001493152-26-015591

Options or other derivatives

  • Chief Medical Officer acquired 621,727 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Agah Ramtin Chief Medical Officer 2026-04-03 Grant or award · Stock Option +621,727 621,727 D
Loading xslF345X06/ownership.xml…